Skip to content. | Skip to navigation

European Coalition on Homeopathic & Anthroposophic Medicinal Products

Navigation

ECHAMP responses

ECHAMP response to the HMPWG public consultation "4th List of First Safe Dilutions (FSD)" PDF (264.3 KB) May 07, 2018
ECHAMP response to the HMPWG public consultation "sixth list entries of stocks for which homeopathic use is justified" PDF (253.8 KB) Mar 28, 2018
ECHAMP response to the HMPWG public consultation "Preamble to the Consolidated list of stocks for which homeopathic use is justified" PDF (403.3 KB) Mar 28, 2018
ECHAMP response to the draft guideline on non-clinical documentation in applications for marketing authorisation/registration of well-established and traditional herbal medicinal products - Revision 1 (EMEA/HMPC/32116/2005 Rev.1) PDF (151.9 KB) Nov 20, 2017
ECHAMP response to the HMPWG public consultation "3rd List of First Safe Dilutions (FSD)" PDF (318.2 KB) Oct 09, 2017
ECHAMP response to the public consultation on the structures of excise duties applied to alcohol and alcoholic beverages PDF (219.0 KB) Jun 14, 2017
ECHAMP response to the HMPWG public consultation "2nd List of First Safe Dilutions (FSD)" PDF (515.0 KB) May 15, 2017
ECHAMP response to the public consultations on possible activities under a "Commission Communication on a One Health Action Plan to support Member States in the fight against Antimicrobial Resistance (AMR)" PDF (160.9 KB) Mar 03, 2017
ECHAMP response to the HMPWG public consultation "fifth list entries of stocks for which homeopathic use is justified" PDF (688.7 KB) Feb 24, 2017
ECHAMP response to the HMPWG public consultation "Questions and answers document on HMPWG quality of homeopathic medicinal product (Q 1-3)" PDF (785.1 KB) Feb 24, 2017
ECHAMP response to the implementation strategy of ICH Q3D guideline, EMA Draft 1 July 2016 PDF (355.7 KB) Aug 03, 2016
ECHAMP response Opinion of the Expert Platform of Effective Ways of Investing in Health PDF (245.7 KB) Jul 14, 2016
ECHAMP response to the "fourth list entries of stocks for which homeopathic use is justified” PDF (301.6 KB) Feb 16, 2016
ECHAMP response to the "Preamble to the consolidated list of justified homeopathic stocks" PDF (181.1 KB) Feb 16, 2016
ECHAMP response to Better Regulation Agenda PDF (393.9 KB) Oct 12, 2015
ECHAMP response on conference on '50 Years of EU Pharma legislation: Achievements and future perspectives' PDF (486.2 KB) Aug 08, 2015
ECHAMP response to the 'External Study Report on the Availability of Medicinal Products for Human Use,’ by Matrix Insight PDF (432.3 KB) Dec 17, 2014
ECHAMP response to public Consultation on Patient Safety and Quality of Care PDF (232.8 KB) Sep 16, 2014
ECHAMP response to the communication from the Commission on effective, accessible and resilient health systems PDF (336.7 KB) Jul 08, 2014
ECHAMP response to Staff Working Document 'Investing in Health' Accompanying the Document Towards Social Investment for Growth PDF (507.8 KB) May 29, 2013
News from ECHAMP

Subscribe here to receive regular information on developments affecting homeopathic and anthroposophic medicinal products in the EU.